Five-year survival rate and factors affecting the survival of hemodialysis patients

References

• 1.
  Teixeira FI, Lopes ML, Silva GA, Santos RF. Survival of hemodialysis patients at a university hospital. J Bras Nefrol 2015; 37: 64-71.
• 2.
  Sharma S, Sarnak MJ. Epidemiology: The global burden of reduced GFR: ESRD, CVD and mortality. Nature Rev Nephrol 2017; 13: 447-448.
• 3.
  Mousavi SSB, Soleimani A, Mousavi MB. Epidemiology of end-stage renal disease in Iran: a review article. Saudi J Kidney Dis Transpl 2014; 25: 697-702.
• 4.
  Control CfD, Prevention. Prevalence of chronic kidney disease and associated risk factors--United States, 1999-2004. MMWR Morb Mortal Wkly Rep 2007; 56: 161-165.
• 5.
  Asgari MR, Motlagh NH, Soleimani M, Ghorbani R. Effect of lidocaine spray on the pain intensity during insertion of vascular needles in hemodialysis patients. Koomesh 2013; 14. (Persian).
• 6.
  Sohrabi Z, Salehi M, Ekramzade M, Sagheb MM, Ayatollahi M, Hassanzade J. Effect of selenium supplement on quality of life in hemodialysis patients. Koomesh 2015; 16. (Persian).
• 7.
  Cheung CM, Hegarty J, Kalra PA. Dilemmas in the management of renal artery stenosis. Br Med Bull 2005; 73: 35-55.
• 8.
  Dicks E, Ravani P, Langman D, Davidson WS, Pei Y, Parfrey PS. Incident renal events and risk factors in autosomal dominant polycystic kidney disease: a population and family-based cohort followed for 22 years. Clin J Am Soc Nephrol 2006; 1: 710-717.
• 9.
  Singapuri MS, Lea JP. Management of hypertension in the end-stage renal disease patient. JCOM 2010; 17.
• 10.
  Jablonski A. The multidimensional characteristics of symptoms reported by patients on hemodialysis. Nephrol Nurs J 2007; 34: 29-37.
• 11.
  Rambod H. Chronic renal failure. Sci Dial Patient Nurs Phys 2008; 3: 1-2.
• 12.
  Abede M, Aghaee N, Gholame F. Evaluation of hemodialysis adequacy on patients undergoing hemodialysis in Razi Hospital in Rasht. J Med Facul Mazanderan Univ Med Sci 2010; 23: 20-27. (Persian).
• 13.
  Ghods AJ, Savaj S. Iranian model of paid and regulated living-unrelated kidney donation. Clin J Am Soc Nephrol 2006; 1: 1136-1145.
• 14.
  Collins AJ, Foley RN, Herzog C, Chavers BM, Gilbertson D, Ishani A, et al. Excerpts from the US renal data system 2009 annual data report. Am J Kidney Dis 2010; 55: S1-420.
• 15.
  Raiesifar A, Torabpour M, Mohsenizad P. Causes of chronic renal failure in hemodialysis patients of Abadan. J Crit Care Nurs 2010; 2: 11-12. (Persian).
• 16.
  Habibi D, Rafiei M, Chehrei A, Shayan Z, Tafaqodi S. Comparison of survival models for analyzing prognostic factors in gastric cancer patients. Asian Pac J Cancer Prev 2018; 19: 749-753.
• 17.
  Montaseri M, Charati JY, Espahbodi F, Mousavi SJ. Five-year survival rate in hemodialysis patients attending Sari Imam Khomeini hospital. J Mazandaran Univ Med Sci 2013; 23: 78-85. (Persian).
• 18.
  Shabankhani B, Kazemnejad A, Zaeri F, Espahbodi F, Ahmadi MH, Mirkazemi R. Survival factors in patients with end-stage renal disease in Mazandaran province, Iran. Iran J Kidney Dis 2016; 10: 79-84.
• 19.
  Yeates A, Hawley C, Mundy J, Pinto N, Haluska B, Shah P. Treatment outcomes for ischemic heart disease in dialysis-dependent patients. Asian Cardiovasc Thorac Ann 2012; 20: 281-291.
• 20.
  Ahuja TS, Grady J, Khan S. Changing trends in the survival of dialysis patients with human immunodeficiency virus in the United States. J Am Soc Nephrol 2002; 13: 1889-1893.
• 21.
  Argyropoulos C, Chang CC, Plantinga L, Fink N, Powe N, Unruh M. Considerations in the statistical analysis of hemodialysis patient survival. J Am Soc Nephrol 2009; 20: 2034-2043.